Download
1758-5996-4-43.pdf 1,34MB
WeightNameValue
1000 Titel
  • Targeting adipose tissue
1000 Autor/in
  1. Haas, Bodo |
  2. Schlinkert, Paul |
  3. Mayer, Peter |
  4. Eckstein, Niels |
1000 Erscheinungsjahr 2012
1000 Art der Datei
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2012-10-27
1000 Erschienen in
1000 Quellenangabe
  • 4(1):43
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2012
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/1758-5996-4-43 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568051/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Two different types of adipose tissues can be found in humans enabling them to respond to starvation and cold: white adipose tissue (WAT) is generally known and stores excess energy in the form of triacylglycerol (TG), insulates against cold, and serves as a mechanical cushion. Brown adipose tissue (BAT) helps newborns to cope with cold. BAT has the capacity to uncouple the mitochondrial respiratory chain, thereby generating heat rather than adenosine triphosphate (ATP). The previously widely held view was that BAT disappears rapidly after birth and is no longer present in adult humans. Using positron emission tomography (PET), however, it was recently shown that metabolically active BAT occurs in defined regions and scattered in WAT of the adult and possibly has an influence on whole-body energy homeostasis. In obese individuals adipose tissue is at the center of metabolic syndrome. Targeting of WAT by thiazolidinediones (TZDs), activators of peroxisome proliferator-activated receptor γ (PPARγ) a 'master' regulator of fat cell biology, is a current therapy for the treatment of type 2 diabetes. Since its unique capacity to increase energy consumption of the body and to dissipate surplus energy as heat, BAT offers new perspectives as a therapeutic target for the treatment of obesity and associated diseases such as type 2 diabetes and metabolic syndrome. Recent discoveries of new signaling pathways of BAT development give rise to new therapeutic possibilities in order to influence BAT content and activity.
1000 Sacherschließung
lokal Thermogenesis
lokal White adipose tissue
lokal Transdifferentiation
lokal ‘Brite’ adipocytes
lokal UCP1
lokal Brown adipose tissue
lokal Positron emission tomography
1000 Fachgruppe
  1. Medizin |
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. http://orcid.org/0000-0002-1213-3527|https://frl.publisso.de/adhoc/creator/U2NobGlua2VydCwgUGF1bA==|https://frl.publisso.de/adhoc/creator/TWF5ZXIsIFBldGVy|https://frl.publisso.de/adhoc/creator/RWNrc3RlaW4sIE5pZWxz
1000 Label
1000 Förderer
  1. Federal Institute for Drugs and Medical Devices
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. Targeting adipose tissue
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6408197.rdf
1000 Erstellt am 2018-06-01T13:03:56.480+0200
1000 Erstellt von 281
1000 beschreibt frl:6408197
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet 2020-01-30T21:33:34.154+0100
1000 Objekt bearb. Mon Jun 04 10:31:49 CEST 2018
1000 Vgl. frl:6408197
1000 Oai Id
  1. oai:frl.publisso.de:frl:6408197 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source